Man Group’s Voyager Therapeutics VYGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-41,200
| Closed | -$234K | – | 2144 |
|
|
2024
Q4 | $234K | Buy |
+41,200
| New | +$234K | ﹤0.01% | 1689 |
|
|
2024
Q3 | – | Sell |
-14,957
| Closed | -$118K | – | 2078 |
|
|
2024
Q2 | $118K | Sell |
14,957
-58,272
| -80% | -$461K | ﹤0.01% | 1812 |
|
|
2024
Q1 | $682K | Buy |
73,229
+57,062
| +353% | +$531K | ﹤0.01% | 1560 |
|
|
2023
Q4 | $136K | Buy |
+16,167
| New | +$136K | ﹤0.01% | 1832 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1765 |
|
|
2023
Q2 | – | Hold |
0
| – | -$237K | – | 2194 |
|
|
2023
Q1 | – | Sell |
-21,077
| Closed | -$129K | – | 1733 |
|
|
2022
Q4 | $129K | Buy |
+21,077
| New | +$129K | ﹤0.01% | 1859 |
|
|
2022
Q2 | – | Sell |
-20,602
| Closed | -$157K | – | 2270 |
|
|
2022
Q1 | $157K | Buy |
+20,602
| New | +$157K | ﹤0.01% | 1913 |
|
|
2021
Q2 | – | Sell |
-17,200
| Closed | -$81K | – | 2024 |
|
|
2021
Q1 | $81K | Sell |
17,200
-106,160
| -86% | -$500K | ﹤0.01% | 1805 |
|
|
2020
Q4 | $882K | Buy |
123,360
+500
| +0.4% | +$3.58K | ﹤0.01% | 1441 |
|
|
2020
Q3 | $1.31M | Sell |
122,860
-2,100
| -2% | -$22.4K | 0.01% | 1315 |
|
|
2020
Q2 | $1.58M | Sell |
124,960
-11,978
| -9% | -$151K | 0.01% | 1140 |
|
|
2020
Q1 | $1.25M | Buy |
136,938
+18,975
| +16% | +$174K | 0.01% | 1047 |
|
|
2019
Q4 | $1.65M | Buy |
117,963
+51,163
| +77% | +$714K | 0.01% | 1377 |
|
|
2019
Q3 | $1.15M | Buy |
+66,800
| New | +$1.15M | ﹤0.01% | 1385 |
|
|
2019
Q1 | – | Sell |
-11,141
| Closed | -$105K | – | 2064 |
|
|
2018
Q4 | $105K | Sell |
11,141
-1,793
| -14% | -$16.9K | ﹤0.01% | 1843 |
|
|
2018
Q3 | $245K | Buy |
+12,934
| New | +$245K | ﹤0.01% | 1978 |
|